Asger Aamund
Chairman of the Board
Chairman of the Board since inception of Bavarian Nordic in
1994.
Re-elected in 2012 for a one-year term. Not independent
Mr. Aamund is President & CEO of A.J. Aamund A/S, a holding
company focusing on the field of biotechnology. He was previously
CEO of Ferrosan, a Danish pharmaindustrial group.
Mr. Aamund is chairman of the board of Rehfeld Partners A/S and
member of the board of A.J. Aamund A/S. He is also chairman of the
Danish Alzheimer Research Foundation.
Mr. Aamund is a Danish national, born in 1940.
The special competencies possessed by
Mr. Aamund that are important for the performance of his duties in
the Company is his management experience from many years in the
Danish and international pharmaceutical industry. As a pioneer in
Danish biotech, Mr. Aamund has had a key role in the establishment
and stock exchange listing as well as commercialization of several
companies and he well experienced in collaborations and partnering
in the international pharmaceutical industry.
